Literature DB >> 24275640

Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin.

M Pacifico de Freitas Segredo1, D M Favero Salvadori2, N S Rocha3, F C Fontes Moretto1, C R Correa1, E A Camargo2, D C de Almeida2, R A Silva Reis1, C M Murbach Freire2, M G Braz2, G Tang4, L S Matsubara1, B B Matsubara1, K-J Yeum5, A L A Ferreira6.   

Abstract

The mechanism of doxorubicin (DOX)-induced cardiotoxicity remains controversial. Wistar rats (n = 66) received DOX injections intraperitoneally and were randomly assigned to 2 experimental protocols: (1) rats were killed before (-24 h, n = 8) and 24 h after (+24 h, n = 8) a single dose of DOX (4 mg/kg body weight) to determine the DOX acute effect and (2) rats (n = 58) received 4 injections of DOX (4 mg/kg body weight/week) and were killed before the first injection (M0) and 1 week after each injection (M1, M2, M3, and M4) to determine the chronological effects. Animals used at M0 (n = 8) were also used at moment -24 h of acute study. Cardiac total antioxidant performance (TAP), DNA damage, and morphology analyses were carried out at each time point. Single dose of DOX was associated with increased cardiac disarrangement, necrosis, and DNA damage (strand breaks (SBs) and oxidized pyrimidines) and decreased TAP. The chronological study showed an effect of a cumulative dose on body weight (R = -0.99, p = 0.011), necrosis (R = 1.00, p = 0.004), TAP (R = 0.95, p = 0.049), and DNA SBs (R = -0.95, p = 0.049). DNA SBs damage was negatively associated with TAP (R = -0.98, p = 0.018), and necrosis (R = -0.97, p = 0.027). Our results suggest that oxidative damage is associated with acute cardiotoxicity induced by a single dose of DOX only. Increased resistance to the oxidative stress is plausible for the multiple dose of DOX. Thus, different mechanisms may be involved in acute toxicity versus chronic toxicity.
© The Author(s) 2014.

Entities:  

Keywords:  DNA damage; Doxorubicin; antioxidant capacity; heart; morphology; rat

Mesh:

Substances:

Year:  2013        PMID: 24275640     DOI: 10.1177/0960327113512342

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  13 in total

1.  Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.

Authors:  Jillian R Gunther; Michelle A Fanale; Jay P Reddy; Mani Akhtari; Grace L Smith; Chelsea C Pinnix; Sarah A Milgrom; Zeinab Abou Yehia; Pamela K Allen; Eleanor M Osborne; Osama Mawlawi; Bouthaina S Dabaja
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-13       Impact factor: 7.038

Review 2.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

3.  Cardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in rats.

Authors:  Dina S El-Agamy; Hany M Abo-Haded; Mohamed A Elkablawy
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-01

4.  The differential effects of green tea on dose-dependent doxorubicin toxicity.

Authors:  Slawomir Mandziuk; Renata Gieroba; Agnieszka Korga; Wlodzimierz Matysiak; Barbara Jodlowska-Jedrych; Franciszek Burdan; Ewa Poleszak; Michał Kowalczyk; Luiza Grzycka-Kowalczyk; Elzbieta Korobowicz; Aleksandra Jozefczyk; Jaroslaw Dudka
Journal:  Food Nutr Res       Date:  2015-12-21       Impact factor: 3.894

5.  Evaluation of the phytochemical composition and protective activities of methanolic extracts of Centaurea borysthenica and Centaurea daghestanica (Lipsky) Wagenitz on cardiomyocytes treated with doxorubicin.

Authors:  Agnieszka Korga; Aleksandra Józefczyk; Grażyna Zgórka; Mateusz Homa; Marta Ostrowska; Franciszek Burdan; Jarosław Dudka
Journal:  Food Nutr Res       Date:  2017-07-06       Impact factor: 3.894

6.  Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.

Authors:  Marianne K O Grant; Davis M Seelig; Leslie C Sharkey; Beshay N Zordoky
Journal:  Biol Sex Differ       Date:  2017-01-07       Impact factor: 5.027

7.  Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment.

Authors:  Agnieszka Korga; Marta Ostrowska; Magdalena Iwan; Mariola Herbet; Jaroslaw Dudka
Journal:  FEBS Open Bio       Date:  2019-04-11       Impact factor: 2.693

8.  Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.

Authors:  Hui Lin; Jie Zhang; Tingjuan Ni; Na Lin; Liping Meng; Feidan Gao; Hangqi Luo; Xiatian Liu; Jufang Chi; Hangyuan Guo
Journal:  J Cell Mol Med       Date:  2019-06-21       Impact factor: 5.310

9.  Ethanol extracts of Allium sp. regulate cyclooxygenase-2 and E-cadherin expression in gastric cancer MKN74 cell line and enhance doxorubicin toxicity.

Authors:  Agnieszka Korga; Marta Ostrowska; Magdalena Iwan; Małgorzata Skierucha; Aleksandra Józefczyk; Piotr Pawłowski; Jarosław Dudka; Ryszard Maciejewski; Robert Sitarz
Journal:  Food Nutr Res       Date:  2019-06-25       Impact factor: 3.894

10.  Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells.

Authors:  Agnieszka Korga; Marta Ostrowska; Aleksandra Jozefczyk; Magdalena Iwan; Rafal Wojcik; Grazyna Zgorka; Mariola Herbet; Gemma Gomez Vilarrubla; Jaroslaw Dudka
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-03       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.